{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:19:58Z","timestamp":1791296398920,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40620-015-0248-3","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T10:38:57Z","timestamp":1447756737000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Treatment of IgA nephropathy"],"prefix":"10.1093","volume":"29","author":[{"given":"Claudio","family":"Pozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"key":"248_CR1","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1038\/kisup.2012.23","volume":"2","author":"KDIGO clinical practice guidelines for glomerulonephritis","year":"2012","unstructured":"KDIGO clinical practice guidelines for glomerulonephritis (2012) Chapter 10: immunoglobulin A nephropathy. Kidney Int Suppl 2:S209\u2013S217","journal-title":"Kidney Int Suppl"},{"key":"248_CR2","first-page":"694","volume":"74","author":"J Berger","year":"1968","unstructured":"Berger J, Hinglais N (1968) Le depots intercapillaire d\u2019IgA-IgG. J Urol Nephrol 74:694\u2013695","journal-title":"J Urol Nephrol"},{"key":"248_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000422388","volume":"104","author":"D Chauveau","year":"1993","unstructured":"Chauveau D, Droz D (1993) Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1\u20135","journal-title":"Contrib Nephrol"},{"key":"248_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2215\/CJN.00330106","volume":"1","author":"GB Appel","year":"2006","unstructured":"Appel GB (2006) To treat or not to treat IgA nephropathy? That is the question! Clin J Am Soc Nephrol 1:347\u2013348","journal-title":"Clin J Am Soc Nephrol"},{"key":"248_CR5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2006040347","volume":"18","author":"R Coppo","year":"2007","unstructured":"Coppo R, Peruzzi L, Amore A et al (2007) IgACE: a placebo controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880\u20131888","journal-title":"J Am Soc Nephrol"},{"issue":"9156","key":"248_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","volume":"353","author":"C Pozzi","year":"1999","unstructured":"Pozzi C, Bolasco PG, Fogazzi GB et al (1999) Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353(9156):883\u2013887","journal-title":"Lancet"},{"issue":"1","key":"248_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","volume":"15","author":"C Pozzi","year":"2004","unstructured":"Pozzi C, Andrulli S, Del Vecchio L et al (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15(1):157\u2013163","journal-title":"J Am Soc Nephrol"},{"key":"248_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2008.07.029","volume":"53","author":"J Lv","year":"2009","unstructured":"Lv J, Zhang H, Chen Y et al (2009) Combination therapy of prednisolone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 53:26\u201332","journal-title":"Am J Kidney Dis"},{"key":"248_CR9","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1093\/ndt\/gfp356","volume":"24","author":"C Manno","year":"2009","unstructured":"Manno C, Torres DD, Rossini M et al (2009) Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant 24:3694\u20133701","journal-title":"Nephrol Dial Transplant"},{"key":"248_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1681\/ASN.V131142","volume":"13","author":"FW Ballardie","year":"2002","unstructured":"Ballardie FW, Roberts ISD (2002) Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 13:142\u2013148","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"248_CR11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ki.2009.499","volume":"77","author":"SCW Tang","year":"2010","unstructured":"Tang SCW, Tang AWC, Wong SSH et al (2010) Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int 77(6):543\u2013549","journal-title":"Kidney Int"},{"issue":"10","key":"248_CR12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2010010117","volume":"21","author":"C Pozzi","year":"2010","unstructured":"Pozzi C, Andrulli S, Pani A, Scaini P, Del Vecchio L, Fogazzi G, Vogt B, De Cristofaro V, Allegri L, Cirami L, Procaccini AD, Locatelli F (2010) Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol 21(10):1783\u20131790","journal-title":"J Am Soc Nephrol"},{"key":"248_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5301\/jn.5000110","volume":"26","author":"C Pozzi","year":"2013","unstructured":"Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi GB, Pecchini P, Del Vecchio L, Rustichelli R, Semeraro L, Locatelli F (2013) IgA nephropathy with severe chronic renal failure: a randomized controller trial with corticosteroids and azathioprine. J Nephrol 26:86\u201393","journal-title":"J Nephrol"},{"key":"248_CR14","doi-asserted-by":"crossref","unstructured":"Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C (2015) Changes in proteinuria and side effects of steroids alone or in combination with azathioprine at different stages of IgA nephropathy (submitted)","DOI":"10.2215\/CJN.02300215"},{"issue":"9","key":"248_CR15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"248_CR16","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1\u2013S246","journal-title":"Am J Kidney Dis"},{"key":"248_CR17","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","volume":"18","author":"HN Reich","year":"2007","unstructured":"Reich HN, Troyanov S, Scholey JW, Cattran D, For the Toronto Glomerulonephritis Registry (2007) Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 18:3177\u20133183","journal-title":"J Am Soc Nephrol"},{"key":"248_CR18","doi-asserted-by":"crossref","unstructured":"Sarcina C, Tinelli C, Ferrario F, Visciano B, Pani A, De Silvestri A, Fogazzi GB, Del Vecchio L, Terraneo V, Furiani S, Santagostino G, Corghi E, Pozzi C (2015) Corticosteroid treatment influences TA-proteinuria and renal survival in IgA nephropathy (submitted)","DOI":"10.1371\/journal.pone.0158584"},{"key":"248_CR19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1681\/ASN.2014070697","volume":"26","author":"V Tesar","year":"2015","unstructured":"Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts ISD, Cattran D, Coppo R, On behalf of the VALIGA Study of ERA-EDTA Immunonephrology Working Group (2015) Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study. J Am Soc Nephrol 26:2248\u20132258","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-015-0248-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0248-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:56Z","timestamp":1777564616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/1\/21\/8371247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s40620-015-0248-3","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}